首页 › 基金 › LUMINUS MANAGEMENT LLC › MIST

LUMINUS MANAGEMENT LLC 对 MIST 的持仓历史

MILESTONE PHARMACEUTICALS IN · 医疗保健

LUMINUS MANAGEMENT LLC 在 Q3 2026 的 13F 申报中披露持有 MIST(MILESTONE PHARMACEUTICALS IN)275,000 股,市值约 US$238K,约占其申报组合的 0.15%,在其申报持仓中市值排名第 27 位。 LUMINUS MANAGEMENT LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)275.00K 股
申报持仓市值$238.07K
组合权重0.15%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

LUMINUS MANAGEMENT LLC 对 MIST 的持仓演变

LUMINUS MANAGEMENT LLC 于 Q3 2026 首次披露 MIST 持仓:275,000 股(约 US$238K)。

逐季持仓明细

季度股数金额变化
Q3 2026 275.00K $238.07K 新进

关于 MIST 与 13F 数据

MIST(MILESTONE PHARMACEUTICALS IN)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 MIST,申报仓位最大的包括:Propel Bio Management, LLC (US$8.2M), Pavaki Capital Management LLC (US$8.1M), Simplify Asset Management Inc. (US$2.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MIST 的基金

查看 MIST 的全部基金持有人 →

常见问题

How long has LUMINUS MANAGEMENT LLC held MIST?

LUMINUS MANAGEMENT LLC has disclosed MIST holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is LUMINUS MANAGEMENT LLC's current position in MIST?

As of Q3 2026, LUMINUS MANAGEMENT LLC holds 275.00K shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $238.07K, representing 0.15% of its reported portfolio and ranking #27.

Has LUMINUS MANAGEMENT LLC been buying or selling MIST?

In the latest 13F filing (Q3 2026), LUMINUS MANAGEMENT LLC newly opened its position in MIST.

Which other funds hold MIST?

Other major institutional holders of MIST include Propel Bio Management, LLC, Pavaki Capital Management LLC, Simplify Asset Management Inc., among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.